Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Humalog® Mix50/50(tm) for the Treatment of Insulin Requiring Gestational Diabetes

NCT01613807 is registered in ClinicalTrials.gov with Sansum Diabetes Research Institute as lead sponsor.

NCT NCT01613807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01613807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Humalog® Mix50/50(tm) for the Treatment of Insulin Requiring Gestational Diabetes
Lead sponsor
Sansum Diabetes Research Institute
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2008
Completion date
October 31, 2010
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes mellitus